A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01) A61K 31/00 (2006.01) A61K 31/13 (2006.01) A61K 31/133 (2006.01) A61K 31/7008 (2006.01)
Patent
CA 2314433
The present invention is to develop an agent, which comprises .alpha.- glucosidase inhibitor, for prevention of transition from high-risk IGT to diabetes mellitus, used as prophylaxis for diabetes mellitus, as well as agents for treating high-risk IGT.
L'invention concerne un agent qui comprend un inhibiteur de l'.alpha.-glucosidase, pour la prévention de la transformation par transition de l'intolérance au glucose à haut risque en diabète sucré, utilisé comme agent prophylactique pour le diabète sucré, ainsi que des agents utilisés pour le traitement de l'intolérance au glucose à haut risque.
Nakaoka Ichiro
Odaka Hiroyuki
Suzuki Yoshiharu
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
Takeda Pharmaceutical Company Limited
LandOfFree
Use of alpha-glucosidase inhibitors for treating high-risk... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of alpha-glucosidase inhibitors for treating high-risk..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of alpha-glucosidase inhibitors for treating high-risk... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1517034